Inspire Medical Systems Shares Outstanding 2017-2024 | INSP
- Inspire Medical Systems shares outstanding for the quarter ending September 30, 2024 were 0.031B, a 4.32% increase year-over-year.
- Inspire Medical Systems 2023 shares outstanding were 0.029B, a 4.38% increase from 2022.
- Inspire Medical Systems 2022 shares outstanding were 0.028B, a 2.97% increase from 2021.
- Inspire Medical Systems 2021 shares outstanding were 0.027B, a 4.56% increase from 2020.
Inspire Medical Systems Annual Shares Outstanding (Millions of Shares) |
|
---|---|
2023 | 29 |
2022 | 28 |
2021 | 27 |
2020 | 26 |
2019 | 24 |
2018 | 15 |
2017 | 1 |
2016 | 1 |
Inspire Medical Systems Quarterly Shares Outstanding (Millions of Shares) |
|
---|---|
2024-09-30 | 31 |
2024-06-30 | 30 |
2024-03-31 | 30 |
2023-12-31 | 29 |
2023-09-30 | 29 |
2023-06-30 | 29 |
2023-03-31 | 29 |
2022-12-31 | 28 |
2022-09-30 | 28 |
2022-06-30 | 28 |
2022-03-31 | 28 |
2021-12-31 | 27 |
2021-09-30 | 27 |
2021-06-30 | 27 |
2021-03-31 | 27 |
2020-12-31 | 26 |
2020-09-30 | 27 |
2020-06-30 | 26 |
2020-03-31 | 24 |
2019-12-31 | 24 |
2019-09-30 | 24 |
2019-06-30 | 24 |
2019-03-31 | 23 |
2018-12-31 | 15 |
2018-09-30 | 21 |
2018-06-30 | 14 |
2018-03-31 | 1 |
2017-12-31 | 1 |
2017-09-30 | 1 |
2017-06-30 | 1 |
2017-03-31 | 1 |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $6.055B | $0.625B |
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $11.978B | 0.00 |
Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
Axonics (AXNX) | United States | $3.602B | 1762.00 |
IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
Privia Health (PRVA) | United States | $2.736B | 228.00 |
Enovis (ENOV) | United States | $2.646B | 17.94 |
Omnicell (OMCL) | United States | $2.263B | 74.03 |
Azenta (AZTA) | United States | $2.242B | 127.33 |
10x Genomics (TXG) | United States | $1.925B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Phreesia (PHR) | United States | $1.252B | 0.00 |
Standard BioTools (LAB) | United States | $0.830B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
TruBridge (TBRG) | United States | $0.214B | 62.22 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.139B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.050B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |